In focus · trending topic

NSPR

16 stories · following the connections

InspireMD Reports 132% Increase in CGuard™ EPS Sales for the First Quarter of 2018

By Nasdaq OMXMay 7, 2018, 8:05 PM UTC

InspireMD Schedules First Quarter 2018 Earnings Conference Call

By Nasdaq OMXMay 1, 2018, 11:00 AM UTC

InspireMD Announces Regulatory Approval and Reimbursement to Commercialize both CGuard EPS™ and MGuard™ Prime Products in Vietnam

By Nasdaq OMXApr 30, 2018, 11:34 AM UTC

InspireMD Anticipates Fifth Consecutive Quarter of Sequential Double Digit Growth; Projects 132% Increase in CGuard EPS Sales for the First Quarter of 2018; Total Quarterly Company Sales to Exceed $1 Million

By Nasdaq OMXApr 3, 2018, 2:28 PM UTC

InspireMD Announces First Patient Treated with CGuard™ EPS in India

By Nasdaq OMXMar 5, 2018, 1:07 PM UTC

InspireMD, Inc. Announces Pricing of Public Offering of Common Stock

By Nasdaq OMXFeb 27, 2018, 12:01 PM UTC

InspireMD Announces Exclusive Distribution, Sales and Marketing Agreement for CGuard EPS in South Korea

By Nasdaq OMXFeb 22, 2018, 3:16 PM UTC

InspireMD Announces Commercial Launch and First Sales of CGuard™ EPS in India

By Nasdaq OMXFeb 20, 2018, 2:02 PM UTC